Literature DB >> 29468986

Increased Endothelial Dysfunction and Insulin Resistance in Patients with Klinefelter Syndrome.

Cem Haymana1, Aydogan Aydogdu1, Ibrahim Demirci1, Mustafa Dinc1, Orhan Demir1, Deniz Torun2, Fatih Yesildal3, Coskun Meric1, Yalcin Basaran1, Alper Sonmez1, Omer Azal1.   

Abstract

BACKGROUND AND
OBJECTIVE: Patients with Klinefelter Syndrome (KS) have increased cardiometabolic risk however the pathogenesis is not clear. We investigated the presence of endothelial dysfunction, insulin resistance and inflammation in an unconfounded population of KS.
METHODS: A total of 32 patients with KS (mean age 21.59 ± 1.66 years) and 33 healthy control subjects (mean age: 22.15 ± 1.03 years) were enrolled. The demographic parameters, Asymmetric dimethylarginine (ADMA), homeostatic model assessment of insulin resistance (HOMA-IR) index and highsensitivity C-reactive protein (hs-CRP) levels were measured.
RESULTS: The patients had higher Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), insulin, HOMA-IR and ADMA levels (p < 0.001 for all) and lower High Density Lipoprotein Cholesterol (HDL-C) and total testosterone levels (p=0.002 and p<0.001, respectively), compared to the healthy controls. Total testosterone levels were significantly negatively correlated to ADMA (r = - 0.479, p < 0,001), hs-CRP (r = -0.291, p = 0.034) and positively correlated to HDL-C (r = 0.429, p = 0.001) levels. The multivariate analysis has shown that total testosterone (β = -0.412, p = 0.001) and TG (β = 0.332, p = 0.009) levels were the significant independent determinants of the plasma ADMA levels.
CONCLUSION: The results of the present study show that endothelial dysfunction and insulin resistance are prevalent even in the very young subjects with KS, who have no metabolic or cardiac problems at present. Also, hypogonadism seems to play an important role for increased cardiometabolic risk in patients with KS. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  ADMA; Klinefelter; cardiometabolic risk; endothelial dysfunction; insulin resistance; sex-chromosome.

Mesh:

Substances:

Year:  2018        PMID: 29468986     DOI: 10.2174/1871530318666180220114322

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  2 in total

1.  Moyamoya angiopathy in a case of Klinefelter syndrome.

Authors:  Ritwik Ghosh; Shambaditya Das; Dipayan Roy; Adrija Ray; Julián Benito-León
Journal:  Childs Nerv Syst       Date:  2021-10-10       Impact factor: 1.532

2.  Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry.

Authors:  Rita Indirli; Emanuele Ferrante; Erica Scalambrino; Eriselda Profka; Marigrazia Clerici; Tommaso Lettera; Andreea Liliana Serban; Walter Vena; Alessandro Pizzocaro; Marco Bonomi; Biagio Cangiano; Giulia Carosi; Gherardo Mazziotti; Luca Persani; Andrea Lania; Maura Arosio; Flora Peyvandi; Giovanna Mantovani; Armando Tripodi
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.